Nuo Therapeutics, Inc.
AURX
$1.23
$0.043.36%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 57.27% | 17.10% | -16.47% | 6.97% | -20.29% |
| Total Depreciation and Amortization | 12.04% | 26.38% | 49.30% | 100.98% | 104.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 361.78% | 427.32% | 341.81% | 31.24% | 1,132.26% |
| Change in Net Operating Assets | -121.71% | -162.75% | -41.71% | -1,533.16% | 578.52% |
| Cash from Operations | -190.13% | -43,672.22% | 13.84% | -44.92% | 137.96% |
| Capital Expenditure | -14,782.35% | 99.65% | -- | 100.00% | 58.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14,782.35% | 99.65% | -- | 100.00% | 58.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 6.58% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 453.10% | 6.58% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.85% | -24.99% | 108.52% | -5.88% | 144.10% |